# Maureen Okam

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maureen-okam/

## Facts

| Field | Value |
| --- | --- |
| Citations | 571 |
| Field | Hemoglobinopathies and Related Disorders |
| h-index | 10 |
| i10-index | 10 |
| OpenAlex ID | https://openalex.org/A5067956428 |
| Works | 22 |

## Researcher papers

- [Anemia in Pregnancy](https://scholariq.org/papers/anemia-in-pregnancy/)
- [Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials](https://scholariq.org/papers/iron-supplementation-response-in-iron-deficiency-anemia-analysis-of-five-trials/)
- [Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson](https://scholariq.org/papers/sickle-cell-vaso-occlusion-causes-activation-of-inkt-cells-that-is-decreased-by/)
- [Comparative rates of adverse events with different formulations of intravenous iron](https://scholariq.org/papers/comparative-rates-of-adverse-events-with-different-formulations-of-intravenous/)
- [Refining the value of secretory phospholipase <scp>A</scp><sub>2</sub> as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (<scp>PROACTIVE</scp>)](https://scholariq.org/papers/refining-the-value-of-secretory-phospholipase-scp-a-scp-sub-2-sub-as-a-predictor/)
- [National Trends in Hospitalizations for Sickle Cell Disease in the United States Following the FDA Approval of Hydroxyurea, 1998–2008](https://scholariq.org/papers/national-trends-in-hospitalizations-for-sickle-cell-disease-in-the-united-states/)
- [Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials](https://scholariq.org/papers/iron-deficiency-anemia-treatment-response-to-oral-iron-therapy-a-pooled-analysis/)
- [Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea](https://scholariq.org/papers/phase-1-2-trial-of-vorinostat-in-patients-with-sickle-cell-disease-who-have-not/)
- [Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors](https://scholariq.org/papers/novel-approaches-to-the-treatment-of-sickle-cell-disease-the-potential-of/)
- [NK-Cell and B-Cell Deficiency with a Thymic Mass](https://scholariq.org/papers/nk-cell-and-b-cell-deficiency-with-a-thymic-mass/)

## Researcher topics

- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Blood groups and transfusion](https://scholariq.org/topics/blood-groups-and-transfusion/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.